RANGE IMPACT, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that RANGE IMPACT, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Mar 31, 2018 | $102.4K | Jun 28, 2018 |
| FY2018 | Mar 31, 2017 | $163.4K | Jun 28, 2018 |
| FY2017 | Mar 31, 2016 | $248.3K | Jun 28, 2017 |
| FY2016 | Mar 31, 2015 | $245.7K | Jun 24, 2016 |
| FY2014 | Mar 31, 2014 | $0 | Jun 30, 2014 |
| FY2014 | Mar 31, 2013 | $0 | Jun 30, 2014 |
| FY2012 | Mar 31, 2012 | $0 | May 20, 2013 |
| FY2011 | Mar 31, 2011 | $0 | Feb 15, 2013 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.03M | Mar 31, 2026 |
| FY2025 | Sep 30, 2025 | $569.9K | Mar 31, 2026 |
| FY2025 | Jun 30, 2025 | $1.11M | Mar 31, 2026 |
| FY2024 | Dec 31, 2024 | $579.8K | Mar 31, 2025 |
| FY2024 | Sep 30, 2024 | $2.17M | Mar 31, 2025 |
| FY2024 | Jun 30, 2024 | $2.35M | Mar 31, 2025 |
| FY2024 | Mar 31, 2024 | $3.91M | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | $6.88M | Mar 31, 2025 |
| FY2024 | Sep 30, 2023 | $5.46M | Mar 31, 2025 |
| FY2024 | Jun 30, 2023 | $4.00M | Mar 31, 2025 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($361.1K) | Mar 31, 2025 |
| FY2024 | Sep 30, 2024 | ($392.9K) | Mar 31, 2025 |
| FY2024 | Jun 30, 2024 | ($148.9K) | Mar 31, 2025 |
| FY2024 | Mar 31, 2024 | $18.9K | Mar 31, 2025 |
| FY2024 | Dec 31, 2023 | $1.88M | Mar 31, 2025 |
| FY2024 | Sep 30, 2023 | $2.86M | Mar 31, 2025 |
| FY2024 | Jun 30, 2023 | $845.1K | Mar 31, 2025 |
| FY2024 | Mar 31, 2023 | $649.0K | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $970.5K | Aug 8, 2024 |
| FY2023 | Sep 30, 2022 | $357.8K | Aug 8, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.91M | Mar 31, 2026 |
| FY2025 | Sep 30, 2025 | ($813.0K) | Mar 31, 2026 |
| FY2025 | Jun 30, 2025 | ($1.03M) | Mar 31, 2026 |
| FY2025 | Mar 31, 2025 | $5.10M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($2.44M) | Mar 31, 2026 |
| FY2025 | Sep 30, 2024 | ($4.92M) | Mar 31, 2026 |
| FY2025 | Jun 30, 2024 | ($1.23M) | Mar 31, 2026 |
| FY2025 | Mar 31, 2024 | ($1.21M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($83.0K) | Mar 31, 2025 |
| FY2024 | Sep 30, 2023 | $3.40M | Mar 31, 2025 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($110.0K) | Mar 31, 2026 |
| FY2025 | Sep 30, 2025 | ($719.6K) | Mar 31, 2026 |
| FY2025 | Jun 30, 2025 | ($318.9K) | Mar 31, 2026 |
| FY2025 | Mar 31, 2025 | ($591.4K) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($575.4K) | Mar 31, 2026 |
| FY2025 | Sep 30, 2024 | ($781.3K) | Mar 31, 2026 |
| FY2025 | Jun 30, 2024 | ($87.8K) | Mar 31, 2026 |
| FY2025 | Mar 31, 2024 | ($708.1K) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $124.0K | Mar 31, 2025 |
| FY2024 | Sep 30, 2023 | $1.66M | Mar 31, 2025 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $458.9K | Aug 8, 2024 |
| FY2023 | Dec 31, 2022 | $470.8K | Aug 8, 2024 |
| FY2022 | Dec 31, 2021 | $298.9K | Mar 31, 2023 |
| FY2021 | Mar 31, 2021 | $408.9K | May 19, 2021 |
| FY2021 | Mar 31, 2020 | $1.01M | May 19, 2021 |
| FY2020 | Mar 31, 2019 | $1.74M | Jun 29, 2020 |
| FY2019 | Mar 31, 2018 | $1.90M | Jul 15, 2019 |
| FY2018 | Mar 31, 2017 | $894.0K | Jun 28, 2018 |
| FY2017 | Mar 31, 2016 | $613.1K | Jun 28, 2017 |
| FY2016 | Mar 31, 2015 | $1.13M | Jun 24, 2016 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $123.0K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($1.59M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $438.6K | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($603.8K) | Aug 8, 2024 |
| FY2022 | Dec 31, 2021 | ($1.37M) | Mar 31, 2023 |
| FY2021 | Mar 31, 2021 | ($1.61M) | May 19, 2021 |
| FY2021 | Mar 31, 2020 | ($3.59M) | May 19, 2021 |
| FY2020 | Mar 31, 2019 | ($3.67M) | Jun 29, 2020 |
| FY2019 | Mar 31, 2018 | ($2.89M) | Jul 15, 2019 |
| FY2018 | Mar 31, 2017 | ($1.38M) | Jun 28, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $5.81M | Mar 31, 2023 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $123.24M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $6.19M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $23.79M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $8.23M | Aug 8, 2024 |
| FY2022 | Dec 31, 2021 | $50.9K | Mar 31, 2023 |
| FY2021 | Mar 31, 2021 | $896.8K | May 19, 2021 |
| FY2021 | Mar 31, 2020 | $2.57M | May 19, 2021 |
| FY2020 | Mar 31, 2019 | $6.08M | Jun 29, 2020 |
| FY2019 | Mar 31, 2018 | $675.8K | Jul 15, 2019 |
| FY2018 | Mar 31, 2017 | $1.18M | Jun 28, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $85.45M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $5.36M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $14.22M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $5.29M | Aug 8, 2024 |
| FY2022 | Dec 31, 2021 | $432.6K | Mar 31, 2023 |
| FY2021 | Mar 31, 2021 | $33.4K | May 19, 2021 |
| FY2021 | Mar 31, 2020 | $1.28M | May 19, 2021 |
| FY2020 | Mar 31, 2019 | $1.05M | Jun 29, 2020 |
| FY2019 | Mar 31, 2018 | $353.5K | Jul 15, 2019 |
| FY2018 | Mar 31, 2017 | $800.7K | Jun 28, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.46M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $834.4K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $9.57M | Mar 31, 2025 |
| FY2024 | Dec 31, 2022 | $2.94M | Mar 31, 2025 |
| FY2023 | Dec 31, 2021 | ($381.6K) | Aug 8, 2024 |
| FY2022 | Mar 31, 2021 | $863.4K | Mar 31, 2023 |
| FY2021 | Mar 31, 2020 | $1.28M | May 19, 2021 |
| FY2021 | Mar 31, 2019 | $5.02M | May 19, 2021 |
| FY2020 | Mar 31, 2018 | $322.3K | Jun 29, 2020 |
| FY2019 | Mar 31, 2017 | $374.4K | Jul 15, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2023 | $751.4K | Mar 31, 2026 |
| FY2024 | Dec 31, 2022 | $751.4K | Mar 31, 2025 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($37.71M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($56.88M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($47.08M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($50.21M) | Aug 8, 2024 |
| FY2022 | Dec 31, 2021 | ($49.14M) | Mar 31, 2023 |
| FY2021 | Mar 31, 2021 | ($47.43M) | May 19, 2021 |
| FY2021 | Mar 31, 2020 | ($46.55M) | May 19, 2021 |
| FY2020 | Mar 31, 2019 | ($42.18M) | Jun 29, 2020 |
| FY2019 | Mar 31, 2018 | ($22.04M) | Jul 15, 2019 |
| FY2018 | Mar 31, 2017 | ($17.74M) | Jun 28, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.11M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $167.3K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $2.18M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $442.4K | Aug 8, 2024 |
| FY2022 | Dec 31, 2021 | $38.3K | Mar 31, 2023 |
| FY2021 | Mar 31, 2021 | $884.1K | May 19, 2021 |
| FY2021 | Mar 31, 2020 | $2.39M | May 19, 2021 |
| FY2020 | Mar 31, 2019 | $5.98M | Jun 29, 2020 |
| FY2016 | Mar 31, 2016 | $95.4K | Jun 24, 2016 |
| FY2016 | Mar 31, 2015 | $389.7K | Jun 24, 2016 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.80M | Mar 31, 2026 |
| FY2025 | Aug 31, 2025 | $914.8K | Mar 31, 2026 |
| FY2025 | Nov 30, 2024 | $1.01M | Mar 31, 2026 |
| FY2022 | Dec 31, 2022 | $5.06M | Mar 31, 2023 |
| FY2014 | Mar 31, 2014 | $0 | Jun 30, 2014 |
| FY2014 | Mar 31, 2013 | $580.4K | Jun 30, 2014 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 31, 2026 |
| FY2025 | Sep 30, 2025 | 0 | Mar 31, 2026 |
| FY2025 | Jun 30, 2025 | 0 | Mar 31, 2026 |
| FY2025 | Mar 31, 2025 | 0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 31, 2026 |
| FY2025 | Sep 30, 2024 | 0 | Mar 31, 2026 |
| FY2025 | Jun 30, 2024 | 0 | Mar 31, 2026 |
| FY2025 | Mar 31, 2024 | 0 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 31, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Mar 31, 2025 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 31, 2026 |
| FY2025 | Sep 30, 2025 | 0 | Mar 31, 2026 |
| FY2025 | Jun 30, 2025 | 0 | Mar 31, 2026 |
| FY2025 | Mar 31, 2025 | 0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 31, 2026 |
| FY2025 | Sep 30, 2024 | 0 | Mar 31, 2026 |
| FY2025 | Jun 30, 2024 | 0 | Mar 31, 2026 |
| FY2025 | Mar 31, 2024 | 0 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 31, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Mar 31, 2025 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 112.28M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 104.73M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 101.02M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 78.12M | Aug 8, 2024 |
| FY2022 | Dec 31, 2021 | 51.45M | Mar 31, 2023 |
| FY2021 | Mar 31, 2021 | 50.84M | May 19, 2021 |
| FY2021 | Mar 31, 2020 | 50.84M | May 19, 2021 |
| FY2020 | Mar 31, 2019 | 52.29M | Jun 29, 2020 |
| FY2019 | Mar 31, 2018 | 24.28M | Jul 15, 2019 |
| FY2018 | Mar 31, 2017 | 22.22M | Jun 28, 2018 |